EXOMEGA CONTROL emollient and EXOMEGA ALLERGO emollient
Efficacy and tolerance in dry skin prone to atopic eczema

Status
Status :
Completed
Type of study
Post-marketing study
Min. Age
0
Year old
Max. Age
88
Years old
Gender
All

Brief summary

The objectives of this study were to evaluate the efficacy and tolerance of Exomega Control emollient and Exomega Allergo emollient in dry skin prone to atopic eczema alone and in association with drug treatments.

The subjects' skin was evaluated during 2 dermatological consultations spaced 6 to 8 weeks apart.

Area of application :
Dermatology
Target :
Dry skin prone to atopic eczema
Dermo-cosmetic product :
Exomega Control emollient and Exomega Allergo emollient
Brand :
A-DERMA
Start Date :
04 September 2023
End Date :
14 February 2024
Number of subjects :

626

Countries :
Greece
Italy
Spain
Study ID : AD-RV4660A-2023-01